Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease

Mov Disord. 2021 Apr;36(4):1031-1033. doi: 10.1002/mds.28458. Epub 2021 Jan 6.

Tommaso Schirinzi^#¹, Daniela Maftei^#², Massimo Pieri^{3

4}, Sergio Bernardini^{3

4}, Nicola B Mercuri^{1

5}, Roberta Lattanzi², Cinzia Severini⁶

¹ Department of Systems Medicine, University of Roma Tor Vergata, Rome, Italy.
² Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy.
³ Department of Experimental Medicine, University of Roma Tor Vergata, Rome, Italy.
⁴ Department of Clinical Biochemistry, Tor Vergata University Hospital, Rome, Italy.
⁵ IRCCS Fondazione Santa Lucia, Rome, Italy.
⁶ Department of Biochemistry and Cell Biology, National Research Council of Italy, Rome, Italy.

^# Contributed equally.

No abstract available

Keywords: Parkinson's disease; biomarkers; chemokine; neuroinflammation; prokineticin 2.

Publication types